Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
<h4>Background</h4>WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. We undertook a secondary analysis of data from 30 surveys...
Saved in:
| Main Authors: | Margaret Ewen, Marjolein Zweekhorst, Barbara Regeer, Richard Laing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171284&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin prices, availability and affordability in 13 low-income and middle-income countries
by: David Beran, et al.
Published: (2019-06-01) -
Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases
by: David Beran, et al.
Published: (2025-08-01) -
Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India
by: Rohina Joshi, et al.
Published: (2019-03-01) -
Essential medicines are more available than other medicines around the globe.
by: Yaser T Bazargani, et al.
Published: (2014-01-01) -
Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review.
by: Ali Lotfizadeh, et al.
Published: (2022-01-01)